Lytix Biopharma As Stock Forecast

Sell candidate since Jul 14, 2026 Loss -17.97%

The Lytix Biopharma As stock price fell by -10.82% on the last day (Monday, 10th Aug 2026) from kr8.50 to kr7.58. During the last trading day the stock fluctuated 11.35% from a day low at kr7.40 to a day high of kr8.24. The price has fallen in 8 of the last 10 days and is down by -15.78% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -35 thousand shares and in total, 197 thousand shares were bought and sold for approximately kr1.50 million.

The stock has broken the wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point (kr7.61) are considered to be a "second chance" to get out. According to the fan-theory kr5.94 will represent the new bottom line of the next trend, but it is far too early to say this for certain.

LYTIX.OL Signals & Forecast

There are few to no technical positive signals at the moment. The Lytix Biopharma As stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at kr8.37 and kr9.14. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, July 08, 2026, and so far it has fallen -24.20%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Lytix Biopharma As stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved kr0.84 between high and low, or 11.35%. For the last week the stock has had daily average volatility of 6.94%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (LYTIX.OL) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Lytix Biopharma As to open at kr7.74, and during the day (based on 14 day Average True Range), to move between kr7.29 and kr7.87, which gives a possible trading interval of +/-kr0.587 (+/-8.06%) up or down from last closing price. If Lytix Biopharma As takes out the full calculated possible swing range there will be an estimated 8.06% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ kr8.50, some kr0.92 (12.14%) from the current price of kr7.58, our system finds the risk reward not very attractive.

Is Lytix Biopharma As stock A Buy?

Lytix Biopharma As holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -8.014 Strong Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - kr7.74 ( 2.11%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk